Icatibant | List of Frontiers open access articles

Original Research

Published on 19 Jun 2020

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist

in Experimental Pharmacology and Drug Discovery

Anne Lesage
Christoph Gibson
François Marceau
Horst-Dieter Ambrosi
Jörn Saupe
Werner Katzer
Brigitte Loenders
Xavier Charest-Morin
Jochen Knolle

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00916

9,070 views
12 citations

Review

Published on 12 Mar 2018

Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus

in Hematology

Hilary Longhurst

Frontiers in Medicine

doi 10.3389/fmed.2017.00245

16,064 views
20 citations

Review

Published on 12 Sep 2022

Treatment of hereditary angioedema—single or multiple pathways to the rescue

in Skin Allergy

Anna Valerieva
Hilary J. Longhurst

Frontiers in Allergy

doi 10.3389/falgy.2022.952233

14,782 views
25 citations

Original Research

Published on 12 Jan 2016

In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases

in Cardiovascular and Smooth Muscle Pharmacology

Mélissa Jean
Lajos Gera
Xavier Charest-Morin
François Marceau
Hélène Bachelard

Frontiers in Pharmacology

doi 10.3389/fphar.2015.00306

5,505 views
16 citations

Community Case Study

Published on 12 Nov 2025

Implementation of genetic diagnosis and personalized management of hereditary angioedema in a Chinese regional center: a community case study of three families

in Genetics and Epidemiology

Wenjin Du
Zhaoji Meng
Ke Yang
Qiuxing Zhang
Xianghua Lin
Wenchao Zhang
Weili Guo
Siqin Wang

Frontiers in Allergy

doi 10.3389/falgy.2025.1696666

1,693 views

Original Research

Published on 27 Mar 2018

D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases

in Cardiovascular and Smooth Muscle Pharmacology

Hélène Bachelard
Xavier Charest-Morin
François Marceau

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00273

3,341 views
10 citations

Articles

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist

Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus

Treatment of hereditary angioedema—single or multiple pathways to the rescue

In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases

Implementation of genetic diagnosis and personalized management of hereditary angioedema in a Chinese regional center: a community case study of three families

D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases